148 related articles for article (PubMed ID: 10896042)
1. Phase transfer and characterization of poly(epsilon-caprolactone) and poly(L-lactide) microspheres.
Gadzinowski M; Slomkowski S; Elaïssari A; Pichot C
J Biomater Sci Polym Ed; 2000; 11(5):459-80. PubMed ID: 10896042
[TBL] [Abstract][Full Text] [Related]
2. Bioactive poly(ε-caprolactone) microspheres with tunable open pores as microcarriers for tissue regeneration.
Zhou A; Ye Z; Zhou Y; Tan WS
J Biomater Appl; 2019 Apr; 33(9):1242-1251. PubMed ID: 30782056
[TBL] [Abstract][Full Text] [Related]
3. Lipase-catalyzed biodegradation of poly(epsilon-caprolactone) blended with various polylactide-based polymers.
Li S; Liu L; Garreau H; Vert M
Biomacromolecules; 2003; 4(2):372-7. PubMed ID: 12625734
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(epsilon-caprolactone) nanoparticles in aqueous media.
Coffin MD; McGinity JW
Pharm Res; 1992 Feb; 9(2):200-5. PubMed ID: 1553342
[TBL] [Abstract][Full Text] [Related]
5. Preparation of poly(L-lactide)-based microspheres having a cationic or anionic surface using biodegradable surfactants.
Ouchi T; Toyohara M; Arimura H; Ohya Y
Biomacromolecules; 2002; 3(5):885-8. PubMed ID: 12217030
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyapatite-armored poly(ε-caprolactone) microspheres and hydroxyapatite microcapsules fabricated via a Pickering emulsion route.
Fujii S; Okada M; Nishimura T; Maeda H; Sugimoto T; Hamasaki H; Furuzono T; Nakamura Y
J Colloid Interface Sci; 2012 May; 374(1):1-8. PubMed ID: 22364710
[TBL] [Abstract][Full Text] [Related]
7. Surface modified poly(L-lactide-co-epsilon-caprolactone) microspheres as scaffold for tissue engineering.
Garkhal K; Verma S; Tikoo K; Kumar N
J Biomed Mater Res A; 2007 Sep; 82(3):747-56. PubMed ID: 17326230
[TBL] [Abstract][Full Text] [Related]
8. The effect of epsilon-caproyl/D,L-lactyl unit composition on the hydrolytic degradation of poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone).
Cho H; An J
Biomaterials; 2006 Feb; 27(4):544-52. PubMed ID: 16099497
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers.
Zeng J; Chen X; Liang Q; Xu X; Jing X
Macromol Biosci; 2004 Dec; 4(12):1118-25. PubMed ID: 15586389
[TBL] [Abstract][Full Text] [Related]
10. Preparation of magnetic microspheres based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymers by modified solvent diffusion method.
Men K; Zeng S; Gou M; Guo G; Gu YC; Luo F; Zhao X; Wei Y; Qian Z
J Biomed Nanotechnol; 2010 Jun; 6(3):287-92. PubMed ID: 21179946
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of dexamethasone-loaded poly(D,L-lactic acid) microspheres embedded in poly(ethylene glycol)-poly({varepsilon}-caprolactone)-poly(ethylene glycol) hydrogel for orthopedic tissue engineering.
Fan M; Guo Q; Luo J; Luo F; Xie P; Tang X; Qian Z
J Biomater Appl; 2013 Aug; 28(2):288-97. PubMed ID: 22561978
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(epsilon-caprolactone) for the delivery of bioactive compounds.
Barbato F; La Rotonda MI; Maglio G; Palumbo R; Quaglia F
Biomaterials; 2001 Jun; 22(11):1371-8. PubMed ID: 11336310
[TBL] [Abstract][Full Text] [Related]
13. Biodegradability and biocompatibility of a pH- and thermo-sensitive hydrogel formed from a sulfonamide-modified poly(epsilon-caprolactone-co-lactide)-poly(ethylene glycol)-poly(epsilon-caprolactone-co-lactide) block copolymer.
Shim WS; Kim JH; Park H; Kim K; Chan Kwon I; Lee DS
Biomaterials; 2006 Oct; 27(30):5178-85. PubMed ID: 16797693
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.
Kim BK; Hwang SJ; Park JB; Park HJ
J Microencapsul; 2005 Mar; 22(2):193-203. PubMed ID: 16019904
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of magnetic poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) microspheres.
Gou ML; Qian ZY; Wang H; Tang YB; Huang MJ; Kan B; Wen YJ; Dai M; Li XY; Gong CY; Tu MJ
J Mater Sci Mater Med; 2008 Mar; 19(3):1033-41. PubMed ID: 17701292
[TBL] [Abstract][Full Text] [Related]
16. Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers Incorporated in a Three-Dimensional Printed Poly(Dimethylsiloxane) Cell Macroencapsulation Device.
Scheiner KC; Coulter F; Maas-Bakker RF; Ghersi G; Nguyen TT; Steendam R; Duffy GP; Hennink WE; O'Cearbhaill ED; Kok RJ
J Pharm Sci; 2020 Jan; 109(1):863-870. PubMed ID: 31654660
[TBL] [Abstract][Full Text] [Related]
17. Surface property and in vitro biodegradation of microspheres fabricated by poly(epsilon-caprolactone-b-ethylene oxide) diblock copolymers.
Yu G; Zhang Y; Shi X; Li Z; Gan Z
J Biomed Mater Res A; 2008 Mar; 84(4):926-39. PubMed ID: 17647229
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
Safaei Nikouei N; Lavasanifar A
Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
20. Surfactant-free microspheres of poly(epsilon-caprolactone)/poly (ethylene glycol)/poly(epsilon-caprolactone) triblock copolymers as a protein carrier.
Sun SW; Jeong YI; Kim SH
Arch Pharm Res; 2003 Jun; 26(6):504-10. PubMed ID: 12877563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
